Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Nicola Mathieson
Observed names:
Mathieson, N.,
Mathieson, Nicola,
N Mathieson,
N. Mathieson
Institution:
Hexal (Germany)
Observed institutions:
Novartis (Germany),
Hexal (Germany),
Boehringer Ingelheim (United Kingdom)
OpenAlex ID:
A5113374568
The impact of poor asthma control among asthma patients treated with inhaled corticosteroids plus long-acting β2-agonists in the United Kingdom: a cross-sectional analysis
2017
·
Ian D. Pavord
, Nicola Mathieson
, et al.
·
npj Primary Care Respiratory Medicine
·
101
PDF
Supportive care in patients with cancer during the COVID-19 pandemic
2021
·
M. Aapro
, G.H. Lyman
, et al.
·
ESMO Open
·
59
PDF
A prospective, real-world, multinational study of febrile neutropenia (FN) occurrence in oncology patients receiving chemotherapy with intermediate risk of FN: a MASCC Neutropenia, Infection, and Myelosuppression Study Group initiative
2023
·
Bernardo Leon Rapoport
, Marcial Garcia-Morillo
, et al.
·
Supportive Care in Cancer
·
20
Extrapolation in Practice: Lessons from 10 Years with Biosimilar Filgrastim
2019
·
Pere Gascon
, Andriy Krendyukov
, et al.
·
BioDrugs
·
18
PDF
Febrile neutropenia hospitalization due to pegfilgrastim on-body injector failure compared to single-injection pegfilgrastim and daily injections with reference and biosimilar filgrastim: US cost simulation for lung cancer and non-Hodgkin lymphoma
2019
·
Ali McBride
, Andriy Krendyukov
, et al.
·
Journal of Medical Economics
·
18
Epoetin alfa for the treatment of myelodysplastic syndrome-related anemia: A review of clinical data, clinical guidelines, and treatment protocols
2019
·
Pere Gascón
, Andriy Krendyukov
, et al.
·
Leukemia Research
·
18
PDF
Meta-Analysis Comparing Incidence Of Grade 3 –4 Neutropenia with Alk Inhibitors And Chemotherapy in Patients with Non-Small-Cell Lung Cancer
2019
·
Bernardo Rapoport
, Ramin B Arani
, et al.
·
Future Oncology
·
4
PDF
P17 The burden of ICS/LABA-treated asthma patients in the UK adult population
2013
·
D Price
, N Mathieson
, et al.
·
Thorax
·
4
PDF
A review of the totality of evidence supporting the development and approval of a pegfilgrastim biosimilar (LA-EP2006)
2022
·
Sanjiv S. Agarwala
, Ulrich Nagl
, et al.
·
Current Medical Research and Opinion
·
3
PDF
Superior physical and mental health of healthy volunteers before and five years after mobilized stem cell donation
2022
·
J. Heyn
, S. Bräuninger
, et al.
·
Journal of Translational Medicine
·
3
PDF
Comparison of efficacy and safety of biosimilar filgrastim in a RCT (PIONEER) and real-world practice (MONITOR-GCSF).
2018
·
Nadia Harbeck
, Lillian Yau
, et al.
·
Journal of Clinical Oncology
·
3
Author Correction: The impact of poor asthma control among asthma patients treated with inhaled corticosteroids plus long-acting β2-agonists in the United Kingdom: a cross-sectional analysis
2017
·
Ian D. Pavord
, Nicola Mathieson
, et al.
·
npj Primary Care Respiratory Medicine
·
3
PDF
A review of the totality of evidence supporting the development and approval of a pegfilgrastim biosimilar (LA-EP2006)
2022
·
Agarwala, Sanjiv S.
, Nagl, Ulrich
, et al.
·
Figshare
1834P Febrile neutropenia outside of clinical trials in intermediate-risk patients receiving chemotherapy: A MASCC neutropenia, infection and myelosuppression study group-prospective, real-world study
2020
·
L. Heyman
, M. Garcia-Morillo
, et al.
·
Annals of Oncology
PDF
Méta-analyse comparant l’incidence de la neutropénie de grade 3/4 lors du traitement par inhibiteurs de l’ALK et de chimiothérapie chez les patients atteints d’un CPNPC
2020
·
B. Rapoport
, R. Arani
, et al.
·
Revue des Maladies Respiratoires Actualités
Pf353 Patients With Severe Chronic Neutropenia Subtypes Treated With Biosimilar Filgrastim: a Study by the European Branch of the Severe Chronic Neutropenia International Registry
2019
·
C. Zeidler
, S. Mellor‐Heineke
, et al.
·
HemaSphere
Sp363design of a Multicenter, Non-interventional, Post-authorization Safety Study of Anemic Ckd Patients Receiving Biosimilar Epoetin Alfa
2019
·
David Goldsmith
, Piergiorgio Messa
, et al.
·
Nephrology Dialysis Transplantation
Pf723 Ten Years of Clinical Experience With Biosimilar Filgrastim in Oncology and Haematology
2019
·
P. Gascón
, N. Mathieson
, et al.
·
HemaSphere
Cost Simulation for Febrile Neutropenia Hospitalization in the US Due to Pegfilgrastim on-Body Injector Failure Compared to Single-Injection Pegfilgrastim and Daily Injections with Reference and Biosimilar Filgrastim in Non-Hodgkin Lymphoma
2018
·
Ali McBride
, Andriy Krendyukov
, et al.
·
Blood
Meta-analysis comparing incidence of grade 3/4 neutropenia with ALK inhibitors and chemotherapy, in patients with NSCLC
2018
·
A. Krendyukov
, R. Arani
, et al.
·
Annals of Oncology
PDF
Cost simulation for the US of febrile neutropenia hospitalization due to pegfilgrastim on-body injector failure compared to single-injection pegfilgrastim and daily injections with reference and biosimilar filgrastim in lung cancer
2018
·
A. McBride
, A. Krendyukov
, et al.
·
Annals of Oncology
PDF
Show more works
View as search
Works count:
23
Citation count:
254
H-index:
6
I10-index:
6
Year
Topic
Type